Chronic kidney disease’s progression can lead to problems beyond the kidney as mineral d...

Vifor Pharma adds to chronic kidney disease lineup with pair of acquisitions – MedCity News

Chronic kidney disease’s progression can lead to problems beyond the kidney as mineral deposits form in blood vessel walls and heart valves, limiting blood flow. Vifor Pharma has reached deals to acquire Sanifit Therapeutics and Inositec, two…

 

Read the full article here


-- END RSP MOD -->